Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy

Indian Journal of Clinical Biochemistry

Volumn 21, Issue 2, 2006, Pages 173-176

  Krishnaswamy, P R ^b   Rao, Anjali ^a   Murali, W ^b   Ballal, H Sudarshan ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b MANIPAL HOSPITAL   (India)

Author keywords

Atherosclerosis; Dialysis; HDL cholesterol; Oxidative stress; Transplantation

Indexed keywords

ANTIBODY; ARYLDIALKYLPHOSPHATASE 1; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART PROTECTION; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 33751041486     PISSN: 09701915     EISSN: 09701915     Source Type: Journal    
DOI: 10.1007/BF02912937     Document Type: Article

References (21)

1. Durrington, P.N., Arrol, S. and Mackness, M.I. (1991) Paraoxonase prevents accumulation of lipoperoxidase in low-density lipoprotein. FEBS Lett. 286, 152-154
2. Mackness, M.I., Abbott, C.A., Arrol, S. and Durrington, P.N. (1993) The role of High density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294,829-835
3. Watson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Faull, K.F., Fogelman, A.M. and Navab, M. (1995) Protective effect of high density lipoprotein associated paraoxonase. J. Clin. Invest. 96, 2882-2891
4. Schiavon, R., De Fanti, E., Giavarina, D., Biasioli, S., Cavalcanti, G. and Guidi, G. (1996) Serum paraoxonase activity decreased in uremic patients. Clin. Chim. Acta. 247, 71-80
5. Gyorgy, P., Laszlo, A., Iidiko, S., Zoltan, B., Lajos, L. and Gyorgy, K. (1991) Serum paraoxonase activity changes in uremic and kidney transplanted patients. Nephron 83, 126-131
6. Witztum, J.L. and Steinberg, D. (1991) Role of oxidized low-density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785-92
7. Maggi, E., Bellazzi, R., Falaschi, F., Frattoni, A. and Perani, G., et al. (1994) Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int. 45, 876-83
8. Haagen, L. and Brock, A. (1992) A new automated method for phenotyping arylesterase based upon inhibition of enzymatic hydrolysis of 4-nitrophenlyacetate by phenyl acetate. Eur. J. Clin. Chem. Clin. Biochem. 30, 391-395
9. Chait, A., Brazg, R., Tribble, D. and Krauss, R. (1993) Susceptibility of small, dense, low- Density Lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94, 350-356
10. Aviram, M., Rosenblat, M. and Billecke, S. et al (1999) Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26, 892-904
11. Dantoine, T.F., Debord, J., Charmes, J.P. et al (1998) Decrease of serum paraoxonase activity in chronic renal failure. J. Am. Soc. Nephrol. 9, 2082-2088.
12. Paul, J.L., Sall, N.D., Soni, et al (1993) Lipid peroxidation abnormalities in hemodialysed patients. Nephron 64 , 106-109
13. Cristol, J.P., Canaud, B., Rabesandratana, H., Gaillard, I., Serre, A. and Mion, C (1994) Enhancement of reactive oxygen species production and cell surface markers expression during hemodialysis. Nephrol. Dial. Transplant 9, 389-394.
14. Himmelfarl, J., Lazarus, M. and Hakim, R. (1991) Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am. J. Kidney Dis. 17, 271-276
15. Odetti, P., Garibaldi, S., Gurreri, G., et al (1996) Protein oxidation in hemodialysis and kidney transplantation. Metabolism 45, 1319
16. Cristol, J.P., Maggi, M.F., Vela, C., Descomps, B. and Mourad, G. (1996) Lipid metabolism and oxidative stress in renal transplantation: implications for chronic rejection. Transplant Proc. 28 (5), 2820.
17. Inselmann, G., Blank, M. and Baumann, K. (1988) Cyclosporine A induces lipid peroxidation in microsomes and effects on active and passive glucose transport by brush border membrane vesicles of rat kidney. Res. Commun. Chem. Pathol. Pharmacol. 62, 207.
18. Serino, F., Grevel, J., Napoli, K.L., Kahan, B.D. and Strobel, H.W. (1994) Oxygen radical formation by the cytochrome p 450 system as a cellular mechanism for cyclosporine toxicity. Transplant Proc. 26, 2916.
19. Wang, C. and Salahudeen, A.K. (1995) Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int. 47, 917-934.
20. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., Witztum, J.L. and Beyong, C. (1989) Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924.
21. Esterbauer, H., Gebicki, J., Puhl, H. and Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13, 341-390.